Renee M Luhr Net Worth

The estimated Net Worth of Renee M Luhr is at least $1.44 Миллион dollars as of 31 December 2008. Renee Luhr owns over 1,875 units of Omnicell stock worth over $888,319 and over the last 19 years Renee sold OMCL stock worth over $549,541.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Renee Luhr OMCL stock SEC Form 4 insiders trading

Renee has made over 15 trades of the Omnicell stock since 2006, according to the Form 4 filled with the SEC. Most recently Renee sold 1,875 units of OMCL stock worth $23,138 on 31 December 2008.

The largest trade Renee's ever made was exercising 34,368 units of Omnicell stock on 6 November 2006 worth over $400,731. On average, Renee trades about 8,210 units every 44 days since 2006. As of 31 December 2008 Renee still owns at least 20,625 units of Omnicell stock.

You can see the complete history of Renee Luhr stock trades at the bottom of the page.

What's Renee Luhr's mailing address?

Renee's mailing address filed with the SEC is 1201 CHARLESTON ROAD, , MOUNTAIN VIEW, CA, 94043.

Insiders trading at Omnicell

Over the last 21 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps и Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.

What does Omnicell do?

since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice

Complete history of Renee Luhr stock trades at Omnicell

Omnicell executives and stock owners

Omnicell executives and other stock owners filed with the SEC include:

• Randall Lipps,
  Chairman of the Board, President, Chief Executive Officer
• Peter Kuipers,
  Chief Financial Officer, Executive Vice President
• Scott Seidelmann,
  Executive Vice President and Chief Commercial Officer
• Randall A. Lipps,
  Founder, Exec. Chairman, Pres & CEO
• Nhat Ngo,
  Executive Vice President - Marketing, Strategy and Business Development
• Daniel Johnston,
  Executive Vice President, Chief Legal and Administrative Officer
• Peter J. Kuipers,
  Exec. VP & CFO
• Scott Peter Seidelmann,
  Exec. VP & Chief Commercial Officer
• Christine Mellon,
  Exec. VP, Chief Admin. & People Officer
• Robin Seim,
  Director
• Bruce Scott,
  Independent Director
• James Judson,
  Lead Independent Director
• Joanne Bauer,
  Independent Director
• Mark Parrish,
  Independent Director
• Sara White,
  Independent Director
• Vance Moore,
  Independent Director
• Bruce Smith,
  Independent Director
• Joseph Spears,
  Senior Vice President, Chief Accounting Officer, Corporate Controller
• Jorge R. Taborga,
  Exec. VP of Engineering & Integration Management Officer
• Roxanne Turner,
  VP of Corp. Responsibility & Chief Compliance Officer
• Corey J. Manley,
  Sr. VP & Chief Legal Officer
• Kathleen Nemeth,
  Sr. VP of Investor Relations
• Giri Chodavarapu,
  Sr. VP & Chief Information Officer
• Joseph Brian Spears,
  Sr. VP, Chief Accounting Officer & Corp. Controller
• Gary S Petersmeyer,
  Director
• Jorge R. Taborga,
  Executive VP. Engineering
• J Christopher Drew,
  EVP, Business Development
• Randy D Lindholm,
  Director
• Corey J Manley,
  EVP&CHIEF LEGAL/ADMIN OFFICER
• Nchacha Etta,
  EVP & CFO
• Kaushik Ghoshal,
  
• Marga Ortigas Wedekind,
  Vice President, Marketing
• Donald C Wegmiller,
  Director
• Mary E Foley,
  Director
• William G. Shields,
  Executive Vice President
• Michael D Stevenson,
  Exec. VP, Global Manufacturing
• Joseph E Whitters,
  Director
• William H Jr Younger,
  Director
• Partners Iii Llc Abs,
  10% owner
• Renee M Luhr,
  VP Sales
• Brock Nelson,
  Director
• Brian Robert Rodli,
  Vice President/Marketing
• Charles J Barnett,
  Director
• Benjamin A Horowitz,
  Director
• Timothy T Weglicki,
  10% owner
• John D Jr Stobo,
  Director
• Capital Partners Iii L P Abs,
  10% owner
• John D Higham,
  SVP Marketing
• Kevin L Roberg,
  Director
• John Choma,
  S.V.P. H.R. Emp. Learn & Perf.
• Dennis P Wolf,
  Exec VP, CFO
• Gary E Wright,
  Exec VP Sales
• Donald B Jr Hebb,
  10% owner
• Chusak Siripocanont,
  Sr. VP, Eng., Mfg. & Quality
• Edward Peter Bousa,
  
• Eileen J. Voynick,
  
• Mary Garrett,
  
• Dan S Johnston,
  EVP, EXECUTIVE ADVISOR
• Christine Marie Mellon,
  EVP, EXECUTIVE ADVISOR
• Brian H. Nutt,
  VP, Chief Accounting Officer